HOME › DRUGS › TAFAMIDIS
ACTIVE SUBSTANCE / INN

TAFAMIDIS

Brand name(s): Vyndaqel, VYNDAMAX
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Amyloidosis
NDA212161
ACTIVE SUBSTANCE
Tafamidis
REGULATORS
FDA · EMA
SPONSORS / MAH
FOLDRX PHARMS, Pfizer Europe MA EEIG
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VYNDAMAXNDA212161FOLDRX PHARMSPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VyndaqelPfizer Europe MA EEIGAuthorised16/11/2011Amyloidosis

FULL INTELLIGENCE ON TAFAMIDIS

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →